newsfilter
← Latest News
Business Wire·

Emmaus Life Sciences Announces Strategic Transaction

Enters into North American License and Exclusive Distribution Agreement Emmaus Life Sciences, Inc. (OTCQB:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today